Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free.
Vito FioreAndrea De VitoAgnese ColpaniValentina MancaIvana MaidaGiordano MadedduSergio BabudieriPublished in: Life (Basel, Switzerland) (2022)
The point-of-care testing and pangenotypic DAAs' availability represent one of the most important steps for a fast diagnostic and therapeutical option. Tailored microelimination pathways for every difficult-to-reach/to-treat populations are needed. This would allow us to move more easily towards HCV elimination.